 |
|
|
| |
New Monogram HCV Protease Inhibitor Resistance Test: "Cross-sectional Assessment of 1500 Clinical Samples Submitted for HCV NS3/4A Protease Inhibitor Drug Resistance Testing in the US"
|
| |
| |
Reported by Jules Levin, AASLD Washington, DC, November 1-5, 2013
Sunny S. Choe, Joseph M. Volpe, Jacqueline D. Reeves, Wei Huang, Mojgan Haddad, Christos J. Petropoulos, and Charles M. Walworth*
Monogram Biosciences, Inc. South San Francisco, CA, USA
New Protease Inhibitor (NS3/4A) Drug Resistance Test
http://www.natap.org/2011/HCV/080611_01.htm
LabCorp Introduces HCV Resistance Testing Through Monogram Biosciences With The Launch Of HCV GenoSure® NS3/4A
http://www.natap.org/2011/newsUpdates/090811_13.htm
AASLD/2011: Validation of an HCV NS3/4A Sequencing Assay for Evaluating Resistance to Boceprevir, Telaprevir and Protease Inhibitor Candidates in a Clinical Reference Laboratory Setting - (12/08/11)
|
| |
|
|
|
|
|
